NASDAQ · TKNO
Alpha Teknova, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for TKNO: Nov 04, 2026
Alpha Teknova, Inc. Common Stock is expected to report earnings on 11/04/2026 after market close. The report will be for the fiscal Quarter ending Sep 2026. According to Zacks Investment Research, based on 2 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.06. The reported EPS for the same quarter last year was $-0.08.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-0.06 | $-0.05 | $-0.07 | 2 |
| Dec 2026 | $-0.09 | $-0.09 | $-0.09 | 1 |
| Mar 2027 | $-0.08 | $-0.08 | $-0.08 | 1 |
| Jun 2027 | $-0.07 | $-0.07 | $-0.07 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Fintel · Zacks · RTTNews · MarketBeat- Fintel · Oct 23, 8:50 AM EDTAlpha Teknova Consensus Price Target Raised by 19.05% to $10.93The average one-year price target for Alpha Teknova (NASDAQGM:TKNO) has been revised to $10.93 / share. This is an increase of 19.05% from the prior estimate of $9.18 dated September 29, 2026. These figures represent aggregate analyst targets compiled from multiple sources and d
- Zacks · Oct 23, 7:38 AM EDTAlpha Teknova (TKNO) Stock Jumps 5.1%: Will It Continue to Soar?Alpha Teknova (TKNO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
- Fintel · Oct 22, 4:48 AM EDTAlpha Teknova, Inc. Enters Underwriting Agreement for 8,000,000 Share Public Offering and Announces Preliminary Financial Estimates for the Three Months Ended September 30, 2026Alpha Teknova, Inc. entered into an underwriting agreement on October 20, 2026, with TD Securities (USA) LLC and William Blair & Company, L.L.C. as representatives of the underwriters, relating to an underwritten public offering of 8,000,000 shares of its common stock. The pu
- RTTNews · Oct 20, 11:00 PM EDTTeknova Prices $40 Mln Public Offering At $5 Per Share(RTTNews) – Alpha Teknova (TKNO) on Tuesday said it priced an underwritten public offering of 8 million common shares at $5 each, with expected gross proceeds of $40 million before underwriting discounts, commissions and offering expenses.
- RTTNews · Oct 20, 10:34 PM EDTTeknova Announces Preliminary Q3 Estimates, Launches Proposed Stock Offering; Stock Down 21%(RTTNews) – On Tuesday, Alpha Teknova (TKNO), a producer of reagents for therapies, vaccines and molecular diagnostics, released preliminary, unaudited third-quarter estimates and separately announced a proposed underwritten public offering of common stock.
- Zacks · Oct 1, 11:00 AM EDTAll You Need to Know About Alpha Teknova (TKNO) Rating Upgrade to BuyAlpha Teknova (TKNO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
- RTTNews · Sep 24, 5:26 AM EDTBiotech Stocks At 52-Week Highs – TKNO, MRNA, ATRC, ILMN(RTTNews) – The following biotech stocks reached a 52-week high on September 23, 2026, driven by key catalysts such as positive quarterly reports or results from clinical trials.
- RTTNews · Sep 23, 8:25 AM EDTBiotech Stocks At 52-Week Highs – OMER +13%, TKNO +5%, BLFS, SDGR, INFU(RTTNews) – The following biotech stocks reached a 52-week high on September 22, 2026, driven by key catalysts such as positive quarterly reports or results from clinical trials.
- Zacks · Sep 22, 8:53 AM EDTAlpha Teknova (TKNO) Moves 7.1% Higher: Will This Strength Last?Alpha Teknova (TKNO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
- Fintel · Sep 17, 7:36 PM EDTJefferies Initiates Coverage of Alpha Teknova with BuyFintel reports that on September 17, 2026, Jefferies initiated coverage of Alpha Teknova (NASDAQGM:TKNO) with a Buy recommendation. Prior to this rating action, the stock closed at $7.11 on September 16, 2026. This pre-action close represents a price change of +2.23% over one wee
- RTTNews · Sep 17, 8:15 AM EDTTeknova Unveils Fill-Tek For Customized Single-Use Reagent Orders(RTTNews) – Alpha Teknova, Inc. (TKNO), a producer of critical reagents for life sciences, announced the launch of its proprietary Fill-Tek Dispensing System, designed to provide greater flexibility for custom single-use bag filling.
- MarketBeat · Aug 19, 10:02 PM EDTAlpha Teknova Raises Outlook After Record Q2 Revenue at Sidoti ConferenceAlpha Teknova (NASDAQ:TKNO) Chief Financial Officer Matt Lowell said the provider of laboratory and bioprocessing reagents is seeing renewed growth, reporting record second-quarter revenue and raising its full-year outlook as biopharma funding and life-science end markets improve
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Alpha Teknova, Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.